1Kim, Y-I (2004) Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 13, 511–519.
2Ames, BN (2001) DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 475, 7–20.
3Sanjoaquin, MA, Allen, N, Couto, E, Roddam, AW & Key, TJ (2005) Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 113, 825–828.
4Sauberlich, HE, Kretsch, MJ, Skala, JH, Johnson, HL & Taylor, PC (1987) Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr 46, 1016–1028.
5Sharp, L & Little, J (2004) Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 159, 423–443.
6Rozen, R (1997) Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost 78, 523–526.
7Frosst, P, Blom, HJ, Milos, R, et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111–113.
8Ma, J, Stampfer, MJ, Christensen, B, et al. (1999) A polymorphism of the methionine synthase gene: assocation with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 8, 825–829.
9Guenther, BD, Sheppard, CA, Tran, P, Rozen, R, Matthews, RG & Ludwig, ML (1999) The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocystenemia. Nat Struct Biol 6, 359–365.
10Yamada, K, Chen, Z, Rozen, R & Mathews, RG (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci U S A 98, 14853–14858.
11Brockton, NT (2006) Localized depletion: the key to colorectal cancer risk mediated by MTHFR genotype and folate? Cancer Causes Control 17, 1005–1016.
12van der Put, NMJ, Gabreels, F, Stevens, EMB, Smeitink, JA, Trijbels, FJ, Eskes, TK, van den Heuvel, LP & Blom, HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Human Genet 62, 1044–1051.
13Chango, A, Boisson, F, Barbe, F, et al. (2000) The effect of 677C-T and 1298A-C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr 83, 593–596.
14Hubner, RA & Houlston, RS (2006) MTHFR C677T and colorectal cancer risk: a meta-analysis of 25 populations. Int J Cancer 120, 1027–1035.
15Huang, Y, Han, S, Li, Y, Mao, Y & Xie, Y (2007) Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis. J Human Genet 52, 73–85.
17Bates, CJ, Mansoor, MA, van der Pols, J, Prentice, A, Cole, TJ & Finch, S (1997) Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over. Eur J Clin Nutr 51, 691–697.
18Erens, B (2000) Alcohol consumption. In The Scottish Health Survey 1998, vol. 1, [Shaw, A, McMunn, A and Fields, J, editors]. Edinburgh: The Stationery Office.
19Boreham, R (2000) Smoking. In The Scottish Health Survey, 1998, vol. 1, [Shaw, A, McMunn, A and Fields, J, editors]. Edinburgh: The Stationery Office.
20Parkin, DM, Whelan, SL, Ferlay, J, Teppo, L & Thomas, DB (2002) Cancer Incidence in Five Continents, vol. VIII, Lyon: IARC.
21Garten, MJ, Abdalla, MI, Reid, DM & Russell, IT (1996) Estimating the point accuracy of population registers using capture-recapture methods in Scotland. J Epidemiol Comm Health 50, 99–103.
23Masson, LF, McNeill, G, Tomany, JO, Simpson, JA, Peace, HS, Wei, L, Grubb, DA & Bolton-Smith, C (2003) Statistical approaches for assessing the relative validity of a food frequency questionnaire: use of correlation coefficients and the κ statistic. Public Health Nutr 6, 313–321.
24van der Put, NMJ & Blom, HJ (2000) Reply to Donnelly. Am J Hum Genet 66, 744–745.
25Holland, B, McCance, RA & Widdowson, EH (1991) McCance and Widdowson's The Composition of Foods, 5th ed., Cambridge, UK: Royal Society of Chemistry.
26Willett, W (1998) Nutritional Epidemiology, 2nd ed., New York: Oxford University Press.
27Hseih, CC, Maisonneuve, P, Boyle, P, Macfarlane, GJ & Robertson, C (1991) Analysis of quantitative data by quantiles in epidemiologic studies: classification according to cases, noncases, or all subjects? Epidemiology 2, 137–140.
28Breslow, NE & Day, NE (1980) Statistical Methods in Cancer Research, vol. 1 – The Analysis of Case-control Studies. IARC Scientific Publication no. 32, vol. 1, Lyon: IARC.
29Hosmer, DW & Lemeshow, S (1989) Applied Logistic Regression. New York: Wiley.
30Macfarlane, TV, Gray, RJM, Kincey, J & Worthington, HV (2001) Factors associated with the temporomandibular disorder, pain dysfunction syndrome (PDS): Manchester case-control study. Oral Dis 7, 321–330.
31Sharp, L (2005) Folate and Genetic Variation in Folate Metabolism in the Aetiology of Colorectal Cancer. PhD Thesis, University of Aberdeen.
32Little, J, Sharp, L, Masson, LF, Brockton, NT, Cotton, SC, Haites, NE & Cassidy, J (2006) Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case-control study in the Grampian region of Scotland. Int J Cancer 119, 2155–2164.
33Botto, LD & Yang, Q (2000) 5,10 Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151, 862–877.
34Sharp, L, Little, J, Schofield, AC, Pavlidou, E, Cotton, SC, Miedzybrodzka, Z, Baird, JO, Haites, NE, Heys, SD & Grubb, DA (2002) Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett 181, 65–71.
35Little, J, Bradley, L, Bray, MS, et al. (2002) Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 156, 300–310.
36Ma, J, Stampfer, MJ, Giovannucci, E, Artigas, C, Hunter, DJ, Fuchs, C, Willett, WC, Selhub, J, Hennekens, CH & Rozen, R (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer. Cancer Res 57, 1098–1102.
38Khlat, M, Cazes, MH, Genin, E & Guiguet, M (2004) Robustness of case-control studies of genetic factors to population stratification: magnitude of bias and type I error. Cancer Epidemiol Biomarkers Prev 13, 1660–1664.
39Van Guelpen, B, Hultdin, J, Johansson, I, Hallmans, G, Stenling, R, Riboli, E, Winkvist, A & Palmqvist, R (2006) Low folate levels may protect against colorectal cancer. Gut 55, 1461–1466.
40Wei, EK, Giovannucci, E, Wu, K, Rosner, B, Fuchs, CS, Willett, WC & Colditz, GA (2004) Comparison of risk factors for colon and rectal cancer. Int J Cancer 108, 433–442.
41Larsson, SC, Giovannucci, E & Wolk, A (2005) A prospective study of dietary folate intake and risk of colorectal cancer: modification by caffeine intake and cigarette smoking. Cancer Epidemiol Biomarkers Prev 14, 740–743.
42Herbert, V (1987) Recommended dietary intakes (RDI) of folate in humans. Am J Clin Nutr 45, 661–670.
43Yang, Q & Erickson, JD (2003) Influence of reporting error on the relation between blood folate concentrations and reported folic acid-containing dietary supplement use among reproductive-aged women in the United States. Am J Clin Nutr 77, 196–203.
44Freudenheim, JL, Graham, S, Marshall, JR, Haughey, BP, Cholewinski, S & Wilkinson, G (1991) Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 20, 368–374.
45Meyer, F & White, E (1993) Alcohol and nutrients in relation to colon cancer in middle-aged adults. Am J Epidemiol 138, 225–236.
46Ferraroni, M, La Vecchia, C, D'Avanzo, B, Negri, E, Franceschi, S & Decarli, A (1994) Selected micronutrient intake and the risk of colorectal cancer. Br J Cancer 70, 1150–1155.
47Tseng, M, Murray, SC, Kupper, LL & Sandler, RS (1996) Micronutrients and the risk of colorectal adenomas. Am J Epidemiol 144, 1005–1014.
48Slattery, ML, Schaffer, D, Edwards, SL, Ma, KN & Potter, JD (1997) Are dietary factors involved in DNA methylation associated with colon cancer? Nutr Cancer 28, 52–62.
49White, E, Shannon, JS & Patterson, RE (1997) Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiol Biomarkers Prev 6, 769–774.
50Giovannucci, E, Rimm, EB, Ascherio, A, Stampfer, MJ, Colditz, GA & Willett, WC (1995) Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 87, 265–273.
51Great British National Food Survey Committee, Ministry of Agriculture, Fisheries and Food (1999) National Food Survey 1998 Annual Report on Food Expenditure, Consumption and Nutrient Intakes. London: The Stationery Office.
52Bailey, LB (2004) Folate and vitamin B12 recommended intakes and status in the United States. Nutr Rev 62, S14–S20.
53Finch, S, Doyle, W, Lowe, C, Bates, CJ, Prentice, A, Smithers, G & Clarke, PC (1998) National Diet and Nutrition Survey: People Aged 65 and Over. 1. Report of the Diet and Nutrition Survey. London: The Stationery Office.
54Keku, T, Millikan, R, Worley, K, Winkel, S, Eaton, A, Biscocho, L, Martin, C & Sandler, R (2002) 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev 11, 1611–1621.
55Giovannucci, E, Stampfer, MJ, Colditz, GA, Hunter, DJ, Fuchs, C, Rosner, BA, Speizer, FE & Willett, WC (1998) Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 129, 517–524.
56Kato, I, Dnistrian, AM, Schwartz, M, Toniolo, P, Koenig, K, Shore, RE, Akhmedkhanov, A, Zeleniuch-Jacquotte, A & Riboli, E (1999) Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer 79, 1917–1921.
57Harnack, L, Jacobs, DR, Nicodemus, K, Lazovich, D, Anderson, K & Folsom, AR (2002) Relationship of folate, vitamin B6, vitamin B12, and methionine intake to incidence of colorectal cancers. Nutr Cancer 43, 152–158.
58La Vecchia, C, Negri, E, Pelucchi, C & Franceschi, S (2002) Dietary folate and colorectal cancer. Int J Cancer 102, 545–547.
59Terry, P, Jain, M, Miller, AB, Howe, GR & Rohan, TE (2002) Dietary intake of folic acid and colorectal cancer risk in a cohort of women. Int J Cancer 97, 864–867.
60Su, LJ & Arab, L (2001) Nutritional status of folate and colon cancer risk: evidence from NHANES I epidemiologic follow-up study. Ann Epidemiol 11, 65–72.
61Ogino, S & Wilson, RB (2003) Genotype and haplotype distributions of MTHFR 677C>T and 1298A>C single nucleotide polymorphisms: a meta-analysis. J Human Genet 48, 1–7.
62Chen, J, Giovannucci, E, Kelsey, K, Rimm, EB, Stampfer, MJ, Colditz, GA, Spiegelman, D, Willett, WC & Hunter, DJ (1996) A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 56, 4862–4864.
63Le Marchand, L, Donlon, T, Hankin, JH, Kolonel, LN, Wilkens, LR & Seifried, A (2002) B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 13, 239–248.
64Slattery, ML, Potter, JD, Samowitz, W, Schaffe, D & Leppert, M (1999) Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 8, 513–518.
65Chen, J, Ma, J, Stampfer, MJ, Palomeque, C, Selhub, J & Hunter, D (2002) J. Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogenetics 12, 339–342.
66Little, J, Sharp, L, Duthie, S & Narayanan, S (2003) Colon cancer and genetic variation in folate metabolism: the clinical bottom line. J Nutr 133, 3758S–3766S.
67Narayanan, S, McConnell, J, Little, J, Sharp, L, Piyathilake, CJ, Powers, H, Basten, G & Duthie, SJ (2004) Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes in vivo. Cancer Epidemiol Biomarkers Prev 13, 1436–1443.
68Crott, JW, Mashiyama, ST, Ames, BN & Fenech, MF (2001) Methylenetetrahydrofolate reductase C677T polymorphism does not alter folic acid deficiency-induced uracil incorporation into primary human lymphocyte DNA in vitro. Carcinogenesis 22, 1019–1025.
69Andreassi, MG, Botto, N, Cocci, F, Battaglia, D, Antonioli, E, Masetti, S, Manfredi, S, Colombo, MG, Biagini, A & Clerico, A (2003) Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum Genet 112, 171–177.
70Zijno, A, Andreoli, C, Leopardi, P, Marcon, F, Rossi, S, Caiola, S, Verdina, A, Galati, R, Cafolla, A & Crebelli, R (2003) Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects. Carcinogenesis 24, 1097–1103.
71Kimura, M, Umegaki, K, Higuchi, M, Thomas, P & Fenech, M (2004) Methylenetetrahydrofolate reductase C677T polymorphism, folic acid and riboflavin are important determinants of genome stability in cultured human lymphocytes. J Nutr 134, 48–56.
72Friso, S, Girelli, D, Trabetti, E, Olivieri, O, Guarini, P, Pignatti, PF, Corrocher, R & Choi, SW (2005) The MTHFR 1298A>C polymorphism and genomic DNA methylation in human lymphocytes. Cancer Epidemiol Biomarkers Prev 14, 938–943.
73Bagley, PJ & Selhub, J (1998) A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci USA 95, 13217–13220.
74Kawakami, K, Ruszkiewicz, A, Bennett, G, Moore, J, Watanabe, G & Iacopetta, B (2003) The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase. Clin Cancer Res 9, 5860–5865.